Mark Pruzanski, CEO & President at INTERCEPT PHARMACEUTICALS INC (ICPT), bought 7,812 shares at $64.00 ($500K) on 2018-04-09, disclosed to the SEC on 2018-04-09.
Seasonal purchase ($500k) by CEO & President — this insider has traded ICPT in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ICPT | SELL | 2019-11-27 | $5.0M | — | Filing → |
| ICPT | SELL | 2018-11-16 | $9.1M | — | Filing → |
| ICPT | SELL | 2017-10-04 | $180K | — | Filing → |